Please find the enclosed newspaper publication for your information
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Godavari Drugs Limited submitted newspaper publications of its Q4 and full year FY2026 financial results. For the quarter ended March 31, 2026, the company reported total income of Rs. 3,330.43 lakhs and net profit after tax of Rs. 129.08 lakhs. For the full year ended March 31, 2026, total income was Rs. 10,661.32 lakhs with net profit after tax of Rs. 408.91 lakhs. Comparing to FY2025 where total income was Rs. 11,432.73 lakhs and net profit was Rs. 438.00 lakhs, the company experienced a decline of approximately 6.7% in revenue and 6.6% in net profit year-on-year. Earnings per share for FY2026 stood at Rs. 5.43 (basic) and Rs. 5.36 (diluted). The results were approved by the board on May 27, 2026 and reviewed by the audit committee.
The company reported a year-on-year decline in both revenue and profitability for FY2026. Shareholders may note the reduced earnings compared to the previous fiscal year, though the company remains profitable.